{"id":611,"date":"2024-05-08T23:47:18","date_gmt":"2024-05-08T23:47:18","guid":{"rendered":"https:\/\/komum.datacenter.is\/?page_id=611"},"modified":"2025-01-10T16:06:50","modified_gmt":"2025-01-10T16:06:50","slug":"program","status":"publish","type":"page","link":"https:\/\/komum.is\/nps2025\/program\/","title":{"rendered":"Program"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Preliminary program<\/h4>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n

4th Nordic Platelet Symposium<\/strong>
Reykjavik 28. \u2013 29. March 2025<\/strong><\/p>\n

Day 1: March 28, 2025<\/strong><\/p>\n

9:30 \u2013 11:30 <\/strong>
Immune Thrombocytopenia<\/strong>
(Chairs: Waleed Ghanima and John Semple)<\/p>\n

    \n
  1. The Pathophysiology of ITP – what have we learned since the 3rd platelet symposium?<\/em> (Sylvain Audia, Dijon, France)<\/li>\n
  2. The role of molecular biology in predicting response to treatment of ITP?<\/em> (Tomas Jose Gonzales-Lopez, Dept. of Haematology, Burgos Spain)<\/li>\n
  3. Real World Evidence exploring the potentials of existing agents <\/em>(Guillaume Moulis, Toulouse, France)<\/li>\n
  4. ITP: New targets, new agents, and new possibilities<\/em> (Galina Tsykunova, Oslo University Hospital, Norway)<\/li>\n
  5. The Potential Role of Artificial Intelligence in Advancing Immune Thrombocytopenia Research<\/em> (Drew Provan, Centre for Immunology, London UK and Waleed Ghanima, Oslo University Hospital Norway)<\/li>\n<\/ol>\n

    \u00a0<\/p>\n

    11:30 \u2013 11:45<\/strong>
    Coffee Break<\/strong><\/p>\n

    \u00a0<\/p>\n

    11:45 \u2013 13:15<\/strong>
    Platelet Clinical Lab<\/strong>
    (Chair: Marie-Therese Ahlen)<\/p>\n

      \n
    1. Assessment of platelet phenotypes by immunofluorescence microscopy on peripheral blood smears<\/em> (Carlo Zaninetti, Institute for Transfusion Medicine, Greifswald University Hospital, Germany)<\/li>\n
    2. Platelet Function Studies<\/em> (Timea Szanto, Helsinki University Hospital, Finland)<\/li>\n
    3. The APAC Antiplatelet-Anticoagulant Story<\/em> (Riitta Lassilla, Helsinki University Hospital, Finland)<\/li>\n<\/ol>\n

      \u00a0<\/p>\n

      13:15 \u2013 14:00<\/strong>
      Lunch Break<\/strong><\/p>\n

      \u00a0<\/p>\n

      14:00 \u2013 15:30<\/strong>
      Whole Genome Sequencing in Platelet Disorders<\/strong>
      (Chairs: Mimi Kjaersgaard and Eva Lein\u00f8e)<\/p>\n

        \n
      1. WGS and inherited thrombocytopenia – new kids in the block<\/em> (Eva Lein\u00f8e, Dept. Haematology and Genomic Medicine, Rigshospitalet, Copenhagen, Denmark)<\/li>\n
      2. An evidence-based framework to evaluate the Clinical Validity of Gene-Disease Associations<\/em> (Andreas \u00d8rslev Rasmussen, Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark)<\/li>\n
      3. Outcome of WGS in ITP \u2013 pilot study<\/em> (Eva Zetterberg, Coagulation Unit, Skaane University Hospital, Malm\u00f6, Sweden)<\/li>\n<\/ol>\n

        \u00a0<\/p>\n

        15:30 \u2013 15:45<\/strong>
        Coffee Break<\/strong><\/p>\n

        \u00a0<\/p>\n

        15:45 \u2013 16:30<\/strong>
        Nordic Platelet Symposium Keynote Lecture<\/strong>
        Hemostasis without clot formation \u2013 how platelets guard the vasculature in inflammation, infection, and malignancy<\/em> (Steffen Massberg, Munich University Hospital, Germany)<\/p>\n

        16.30 \u2013 17:15<\/strong>
        Abstract Presentations<\/strong><\/p>\n

        \u00a0<\/p>\n

        19:30<\/strong>
        Dinner<\/strong><\/p>\n

        Day 2: March 29, 2025<\/strong><\/p>\n

        9:00 \u2013 9.40\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombotic Thrombocytopenic Purpura\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>(Chair: \u00d3lafur Eysteinn Sigurj\u00f3nsson)<\/p>\n

          \n
        1. U<\/em>pdate on TTP treatment<\/em> (Marie Scully, University College London Hospitals UK)<\/li>\n<\/ol>\n

          \u00a0<\/p>\n

          9:40 \u2013 11.10<\/strong>
          Platelets in Other Diseases<\/strong>
          (Chairs: Riitta Lassila and John Semple)<\/p>\n

            \n
          1. The association between BDNF, platelet dysfunction, and cognitive impairment<\/em> (Marie Lordkipanidze, Research Center, Montreal Heart Institute, Montreal, Quebec, Canada)<\/li>\n
          2. EV and serum markers and VTE population-based studies<\/em> (Omri Snir, Troms\u00f8, Norway)<\/li>\n
          3. Platelet Factor 4 associated syndromes<\/em> (Hanna Pitk\u00e4nen, Helsinki University Hospital, Finland)<\/li>\n<\/ol>\n

            \u00a0<\/p>\n

            11:10 \u2013 11:30<\/strong>
            Coffee Break<\/strong><\/p>\n

            \u00a0<\/p>\n

            11.30 -13.00\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Platelets and Complement disease<\/strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0(Chair: Eva Zetterberg)<\/p>\n

              \n
            1. The complement and contact systems in thrombotic kidney disease (Diana Karpman<\/em>, Department of Paediatrics, Skane University Hospital, Lund, Sweden)<\/li>\n<\/ol>\n

              \u00a0<\/p>\n

                \n
              1. The paradigm of complement inhibition in PNH (<\/em>Alexandros Arvanitakis, Dept. of Hematology, Skane University Hospital, Malmoe, Sweden)<\/li>\n<\/ol>\n

                \u00a0<\/p>\n

                  \n
                1. Interactions between platelets and complement<\/em> (Per Nilsson<\/em> Institution of Chemistry and Biomedicine, Linn\u00e9 University, Sweden)<\/li>\n<\/ol>\n

                  \u00a0<\/strong><\/p>\n

                    \n
                  1. 00 \u2013 14.00<\/strong>
                    Lunch Break<\/strong><\/li>\n<\/ol>\n\n

                    \u00a0<\/p>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

                    \n\t\t\t\t\t
                    \n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                    Preliminary program 4th Nordic Platelet SymposiumReykjavik 28. \u2013 29. March 2025 Day 1: March 28, 2025 9:30 \u2013 11:30 Immune Thrombocytopenia(Chairs: Waleed Ghanima and John Semple) The Pathophysiology of ITP – what have we learned since the 3rd platelet symposium? (Sylvain Audia, Dijon, France) The role of molecular biology in predicting response to treatment of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-611","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/pages\/611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/comments?post=611"}],"version-history":[{"count":11,"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/pages\/611\/revisions"}],"predecessor-version":[{"id":890,"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/pages\/611\/revisions\/890"}],"wp:attachment":[{"href":"https:\/\/komum.is\/nps2025\/wp-json\/wp\/v2\/media?parent=611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}